A Class for Caregivers: Activities of Daily Living Made Easier
Dr. Pelak will discuss the new Food and Drug Administration (FD) approved treatment for Alzheimer's disease, Aduhelm (aducanumab) through their accelerated approval pathway, which the FDA describes as being a pathway "used for a drug for a serious or life-threatening illness that provides a meaningful therapeutic advantage over existing treatments...and where there is an expectation of clinical benefit despite some residual uncertainty regarding that benefit."
Speaker: Victoria Pelak, MD
Date: Monday, June 28, 2021
Time: 9-10 am MDT